Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 25% ± 6% | |
glutamatergic neuron | 3 studies | 36% ± 6% | |
astrocyte | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 807.51 | 459 / 459 | 100% | 15.91 | 1118 / 1118 |
esophagus | 100% | 816.05 | 1445 / 1445 | 100% | 14.17 | 183 / 183 |
lung | 100% | 780.30 | 578 / 578 | 100% | 11.66 | 1155 / 1155 |
ovary | 100% | 806.98 | 180 / 180 | 100% | 11.22 | 430 / 430 |
prostate | 100% | 937.82 | 245 / 245 | 100% | 11.56 | 502 / 502 |
uterus | 100% | 1013.09 | 170 / 170 | 100% | 11.73 | 459 / 459 |
thymus | 100% | 839.12 | 653 / 653 | 100% | 11.79 | 604 / 605 |
bladder | 100% | 931.14 | 21 / 21 | 100% | 9.79 | 503 / 504 |
brain | 100% | 649.29 | 2636 / 2642 | 100% | 11.34 | 705 / 705 |
kidney | 100% | 689.64 | 89 / 89 | 100% | 10.89 | 898 / 901 |
stomach | 100% | 583.92 | 359 / 359 | 100% | 10.44 | 285 / 286 |
intestine | 100% | 1066.30 | 966 / 966 | 99% | 10.57 | 524 / 527 |
skin | 100% | 942.04 | 1809 / 1809 | 98% | 12.87 | 464 / 472 |
liver | 100% | 543.17 | 226 / 226 | 98% | 6.52 | 399 / 406 |
pancreas | 98% | 367.42 | 323 / 328 | 99% | 9.68 | 176 / 178 |
adrenal gland | 100% | 701.52 | 258 / 258 | 97% | 7.73 | 223 / 230 |
adipose | 100% | 776.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 741.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.29 | 29 / 29 |
spleen | 100% | 902.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.39 | 1 / 1 |
muscle | 100% | 414.89 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 375.09 | 828 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 832.19 | 878 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 7.50 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
Gene name | ASB7 |
Protein name | Ankyrin repeat and SOCS box protein 7 (ASB-7) Ankyrin repeat and SOCS box containing 7 |
Synonyms | |
Description | FUNCTION: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. . |
Accessions | ENST00000332783.12 [Q9H672-1] Q9H672 H0YMJ1 ENST00000343276.4 [Q9H672-2] ENST00000558747.5 |